(
Montvale,
NJ)
–
Feb. 9, 2010 –
The PDR Network, already the largest distributor of FDA-approved drug
information, Alerts and REMS programs to physicians, has added two top
regulatory and risk executives to its management
team and expanded its REMS and pharmaceutical risk offerings.
Christine Côté, MD,
has joined PDR Network as the Chief Medical Officer. Dr. Côté has over
24 years experience at Johnson & Johnson and Zeneca Pharmaceuticals,
where she held several senior regulatory, clinical and strategic
positions including Chief Scientific Officer for J&J’s Janssen
Pharmaceutica division. Also during her time at J&J, Dr. Côté was
directly involved with the creation of the Health Care Notification
Network, now operated by PDR Network, which sends drug Alerts and REMS
programs to U.S. physicians electronically, replacing paper
notifications and traditional Dear Doctor Letters.
John Loucks has
joined PDR Network’s senior management team as the Vice President of
Sales. Mr. Loucks was previously the Chief Customer Officer
for Relsys, the drug safety solutions company recently acquired by
Oracle Corporation. During his time at Relsys, Mr. Loucks assisted in
the development, sale and implementation of Relsys’ Argus Safety™,
which is the number one drug safety system used by pharmaceutical
manufacturers worldwide.
Dr Côté and Mr.
Loucks join the team at PDR Network as part of the expansion of
medication risk and REMS services that communicate directly with
all prescribing U.S. physicians. PDR Network is the largest distributor
of FDA-required REMS programs for pharmaceutical firms, having
delivered over three million REMS and
drug Alerts to physicians and other prescribers in the past two years.
For more information
about PDR Network, visit
www.pdrnetwork.com.
No comments:
Post a Comment